University Of Wisconsin
Type 2 diabetes associated with higher risk for colorectal cancer
Risk for developing colorectal cancer increased by 47% among individuals with type 2 diabetes, according to results from a cohort study designed to over-represent African Americans and low-income patients.
Tobacco cessation program in primary care cost-effective, increased cessation rates
A tobacco cessation program was cost-effective and increased smoking cessation rates by 7.4%, a study in the American Journal of Preventive Medicine showed.
More than one-third of cancer survivors consume ‘hazardous’ levels of alcohol
Alcohol consumption and potentially hazardous drinking behavior appeared common among cancer survivors and those undergoing cancer treatment, according to study results published in JAMA Network Open.
New Sjӧgren’s syndrome therapies may target BAFF receptors, CD40
DESTIN, Fla. — Multiple potentially new therapies promise to improve the management of patients with Sjӧgren’s syndrome, according to a speaker at the 2023 Congress of Clinical Rheumatology meeting.
One-third of lupus hospitalizations lack post-discharge follow-up care
Approximately one-third of lupus hospitalizations lack post-discharge follow-up care, with “significant disparities” reported among rural and disadvantaged localities, according to Medicare data published in Arthritis Care & Research.
Breast cancer stage, receptor status may help predict recurrence risk
Breast cancer stage and receptor status appeared to predict risk for recurrence among patients with stage I to stage III disease, according to study results published in Cancer.
Surgery before 8 weeks not associated with worse survival in breast cancer
Women who had surgery up to 8 weeks after breast cancer diagnosis did not have worse overall survival than those with earlier times to surgery, according to a case series with more than 373,000 women published in JAMA Surgery.
Comorbidities raise COVID-19 hospital risk for children, young adults with type 1 diabetes
For children and young adults with type 1 diabetes, comorbidities such as obesity and asthma increased the risk for COVID-19 hospitalization, according to study results published in Pediatric Diabetes.
Belimumab effective for cutaneous lupus erythematosus, regardless of SLE, after 20 weeks
PHILADELPHIA — Belimumab demonstrated a strong clinical response and significantly reduced flare risk for patients with cutaneous lupus erythematosus, with or without systemic lupus erythematosus, after 20 weeks, said a presenter here.
‘Comfort level’ driving divide between rheumatologists, nephrologists in lupus nephritis
Recent data has revealed a growing divide between rheumatologists and nephrologists in their therapeutic choices for patients with lupus nephritis, according to researchers from Spherix Global Insights.